Hepatitis B seroprevalence in Latin America

Silveira, Thêmis R; Fonseca, José Carlos da; Rivera, Luis; Fay, Oscar H; Tapia, Roberto; Santos, José I; Urdeneta, Eduardo; Costa Clemens, Sue Ann.
Rev Panam Salud Publica ; 6(6),dic. 1999 ilus, tab
Artículo | PAHOIRIS | ID: phr-8884

Documentos relacionados

  1. Influencing factors and necessity of post-vaccination serologic testing follow-up for HBsAg-positive mothers and their infants: A 5-year prospective study in Zhejiang Province, China (2016-2020).
  2. Prevalence of viral sexually transmitted infections and HPV high-risk genotypes in women in rural communities in the Department of La Paz, Bolivia.
  3. Hepatitis B seroprevalence in Latin America
  4. Anti-HBs levels in children under the age of two years born to HBV carrier mothers after immunoprophylaxis: a multicenter cross-sectional study.
  5. Universal Infant Hepatitis B Virus (HBV) Vaccination for 35 Years: Moving Toward the Eradication of HBV.
  6. Absence of chronicity in infants born to immunized mothers with occult HBV infection in Taiwan.
  7. The relationship of maternal hepatitis B e antigen and response to vaccination of infants born to women with chronic infection.
  8. Timing of primary three-dose hepatitis B vaccination and postvaccination serologic testing among a large cohort of healthy adults.
  9. [Clinical significance and research progress of quantitative hepatitis B virus core antibody measurement].
  10. Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose.